Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIVA: High Dose Vitamin D in HIV Latency
NCT03426592Phase 2Completed
- Sponsor
- University of Melbourne
- Start
- Jan 2018
- Primary completion
- May 2019
- Countries
- 1
01
Overview
A Phase 2 trial of vitamin d in human immunodeficiency virus infection (HIV), sponsored by University of Melbourne. Started Jan 2018; status: completed.
02
Drugs
vitamin d
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT03426592.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03426592.